The potential market is what really gets investors’ attention. One forecast puts the global mRNA cancer-vaccine market at roughly $1.8 billion in 2024 and nearly $7.3 billion by 2030, which would ...

BMS merger rumour that rattled markets to a double UK approval for Eli Lilly's weight loss pill, there's plenty to discover.

Infringed patents support multiple product pipelines, including Factor's allogeneic cancer cell therapy programs Cites need to take action to protect Factor's ability to bring innovative cancer ...